Clustered incidence of adult acute promyelocytic leukemia

Andrew M. Brunner(Harvard University), Amir T. Fathi(Harvard University), Kellie Sprague(Tufts Medical Center), Hossein Sadrzadeh(Boston University), Parul Bhargava(Beth Israel Deaconess Hospital), Wanxing Chai‐Ho(University of California, Los Angeles), Benjamin J. Drapkin(Southwestern Medical Center), J. Mark Sloan(Boston University), Olga Pozdnyakova(Memorial Medical Center), Peter Geon Kim(Massachusetts General Hospital)
Leukemia Research
September 19, 2018
10.1016/j.leukres.2018.09.008
Cited by 5

Related Papers

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients
|Blood|2011|288
Pomalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 1 and 2 trial
|Blood|2016|274
Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish
|Cell|2019|260
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial
|The Lancet Oncology|2021|257
Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer
|Cancer Discovery|2019|238